Is "seronegative" MG explained by autoantibodies to MuSK?

被引：26

作者：

Lindstrom, J ^{[1
]}

机构：

[1] Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA

来源：

NEUROLOGY | 2004年 / 62卷 / 11期

关键词：

D O I：

10.1212/01.WNL.0000129702.41868.A5

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：1920 / 1921

页数：2

共 17 条

[1]

Blaes F, 2000, ANN NEUROL, V47, P504, DOI 10.1002/1531-8249(200004)47:4<504::AID-ANA14>3.3.CO

[2]

2-H

[3] PASSIVE TRANSFER OF SERONEGATIVE MYASTHENIA-GRAVIS TO MICE [J].

BURGES, J ;

VINCENT, A ;

MOLENAAR, PC ;

NEWSOMDAVIS, J ;

PEERS, C ;

WRAY, D .

MUSCLE & NERVE, 1994, 17 (12) :1393-1400

[4] The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo [J].

DeChiara, TM ;

Bowen, DC ;

Valenzuela, DM ;

Simmons, MV ;

Poueymirou, WT ;

Thomas, S ;

Kinetz, E ;

Compton, DL ;

Rojas, E ;

Park, JS ;

Smith, C ;

DiStefano, PS ;

Glass, DJ ;

Burden, SJ ;

Yancopoulos, GD .

CELL, 1996, 85 (04) :501-512

[5] Sleuthing molecular targets for neurological diseases at the neuromuscular junction [J].

Engel, AG ;

Ohno, K ;

Sine, SM .

NATURE REVIEWS NEUROSCIENCE, 2003, 4 (05) :339-352

[6] Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies [J].

Hoch, W ;

McConville, J ;

Helms, S ;

Newsom-Davis, J ;

Melms, A ;

Vincent, A .

NATURE MEDICINE, 2001, 7 (03) :365-368

[7]

Lindstrom JM, 2000, MUSCLE NERVE, V23, P453, DOI 10.1002/(SICI)1097-4598(200004)23:4<453::AID-MUS3>3.0.CO

[8]

2-O

[9] The agrin/muscle-specific kinase pathway: New targets for autoimmune and genetic disorders at the neuromuscular junction [J].

Liyanage, Y ;

Hoch, W ;

Beeson, D ;

Vincent, A .

MUSCLE & NERVE, 2002, 25 (01) :4-16

[10] ANTIBODY-SECRETING CELLS TO ACETYLCHOLINE-RECEPTOR AND TO PRESYNAPTIC MEMBRANE-RECEPTOR IN SERONEGATIVE MYASTHENIA-GRAVIS [J].

LU, CZ ;

LU, L ;

HAO, ZS ;

XIA, DG ;

QAIN, J ;

ARNASON, BGW .

JOURNAL OF NEUROIMMUNOLOGY, 1993, 43 (1-2) :145-149

← 1 2 →